We are live on
!
Find out more
KBC Group Portfolio holdings
AUM
$39.9B
1-Year Est. Return
29.7%
This Fund
S&P 500
This Quarter
Est. Return
+1.08%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$27.3B
AUM Growth
-$28.2B
(-51%)
Cap. Flow
-$28.9B
Cap. Flow
% of AUM
-105.88%
Top 10 Holdings %
Top 10 Hldgs %
23.06%
Holding
1,354
New
88
Increased
57
Reduced
1,096
Closed
66
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$36.3M |
| 2 |
Paycom
PAYC
|
+$30.3M |
| 3 |
Airbnb
ABNB
|
+$26.2M |
| 4 |
Charles River Laboratories
CRL
|
+$22.6M |
| 5 |
Bio-Techne
TECH
|
+$22.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Amazon
AMZN
|
+$1.15B |
| 3 |
Apple
AAPL
|
+$1.01B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$881M |
| 5 |
Comcast
CMCSA
|
+$482M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.21% |
| 2 | Healthcare | 16.15% |
| 3 | Financials | 15.41% |
| 4 | Consumer Discretionary | 12.5% |
| 5 | Communication Services | 11.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Matsons
MATX
$6.11B
| $30K | ﹤0.01% |
+371
| New | +$27.4K |
|
1227
Bristow Group
VTOL
$1.33B
| $30K | ﹤0.01% |
+948
| New | +$27.7K |
|
1228
Webster Financial
WBS
$12.3B
| $30K | ﹤0.01% |
558
-558
| -50% | -$27.8K |
|
1229
Shutterstock
SSTK
$209M
| $29K | ﹤0.01% |
+252
| New | +$27.2K |
|
|
SVC
1230
Service Properties Trust
SVC
$1.05B
| $29K | ﹤0.01% |
517
-517
| -50% | -$29.4K |
|
1231
First Commonwealth Financial
FCF
$2.22B
| $28K | ﹤0.01% |
+2,084
| New | +$27.8K |
|
1232
Adecoagro
AGRO
$1.4B
| $27K | ﹤0.01% |
2,998
-2,998
| -50% | -$28.2K |
|
1233
Gaotu Techedu
GOTU
$405M
| $27K | ﹤0.01% |
8,871
-8,871
| -50% | -$44.8K |
|
|
MNDT
1234
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $27K | ﹤0.01% |
1,500
-1,500
| -50% | -$28.5K |
|
|
BMTX
1235
DELISTED
BM Technologies, Inc.
BMTX
| $25K | ﹤0.01% |
2,857
-2,857
| -50% | -$29.2K |
|
1236
Emergent Biosolutions
EBS
$379M
| $24K | ﹤0.01% |
471
-1,215
| -72% | -$73.6K |
|
1237
Protolabs
PRLB
$1.7B
| $24K | ﹤0.01% |
365
-365
| -50% | -$28.5K |
|
1238
EPR Properties
EPR
$4.89B
| $19K | ﹤0.01% |
375
-375
| -50% | -$19K |
|
|
FL
1239
DELISTED
Foot Locker
FL
| $11K | ﹤0.01% |
240
-240
| -50% | -$13.3K |
|
|
GBT
1240
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $11K | ﹤0.01% |
425
-425
| -50% | -$12.5K |
|
1241
Children's Place
PLCE
$53.8M
| $10K | ﹤0.01% |
135
-135
| -50% | -$12K |
|
1242
Norwegian Cruise Line
NCLH
$9.53B
| $9K | ﹤0.01% |
+321
| New | +$8.17K |
|
1243
American Airlines Group
AAL
$9.82B
| – | – |
-3,880
| Closed | -$82K |
|
|
ADVM
1244
DELISTED
Adverum Biotechnologies
ADVM
| – | – |
-420
| Closed | -$14K |
|
1245
Astec Industries
ASTE
$1.17B
| – | – |
-23,996
| Closed | -$1.51M |
|
1246
Avnet
AVT
$6.86B
| – | – |
-20,924
| Closed | -$838K |
|
1247
Axos Financial
AX
$5.58B
| – | – |
-10,592
| Closed | -$492K |
|
1248
AstraZeneca
AZN
$269B
| – | – |
-2,209
| Closed | -$264K |
|
1249
Compañía de Minas Buenaventura
BVN
$7.68B
| – | – |
-43,870
| Closed | -$398K |
|
1250
Coeur Mining
CDE
$15.1B
| – | – |
-90,640
| Closed | -$804K |
|
Similar funds
HF
KBC Group's Q3 2021 Portfolio in Review
As of Q3 2021, KBC Group held 1,354 positions worth $27.3B, down 51% from $55.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
KBC Group withdrew a net $28.9B in Q3 2021, closing 66 positions and reducing 1,096 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $42.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
Against the trend, KBC Group opened a new position in DoorDash worth $9.43M.
- KBC Group's largest Q3 2021 buy was DoorDash: 45,764 shares worth $9.43M.
- KBC Group added most to Zscaler in Q3 2021, an estimated $36.3M increase.
- KBC Group's biggest Q3 2021 reduction was Microsoft, cutting an estimated $1.57B.
- KBC Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $42.6M.
- KBC Group's ten largest holdings make up 23% of its $27.3B portfolio in Q3 2021.
- KBC Group opened 88 new positions and closed 66 in Q3 2021.
- KBC Group's portfolio value fell 51% quarter-over-quarter to $27.3B.
Based on KBC Group's 13F filing for Q3 2021, filed 10 Nov 2021.